» Articles » PMID: 32066505

Outpatient Balloon Catheter Vs Inpatient Prostaglandin for Induction of Labour (OBLIGE): a Randomised Controlled Trial

Overview
Journal Trials
Publisher Biomed Central
Date 2020 Feb 19
PMID 32066505
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Approximately one in four pregnant women undergo an induction of labour. The purpose of this study is to investigate the clinical effectiveness, safety, and cost-effectiveness for mothers and babies of two methods of cervical ripening - inpatient care for women starting induction with vaginal prostaglandin E2 hormones, or allowing women to go home for 18 to 24 h after starting induction with a single-balloon catheter.

Methods/design: This is a multi-centre randomised controlled trial in New Zealand. Eligible pregnant women, with a live singleton baby in a cephalic presentation who undergo a planned induction of labour at term, will be randomised to outpatient balloon-catheter induction or in-hospital prostaglandin induction. The primary outcome is caesarean section rate. To detect a 24% relative risk reduction in caesarean rate from a baseline of 24.8%, with 80% power and 5% type 1 error, will require 1552 participants in a one to one ratio.

Discussion: If outpatient balloon-catheter induction reduces caesarean section rates, has additional clinical benefits, and is safe, cost-effective, and acceptable to women and clinicians, we anticipate change in induction of labour practice around the world. We think that home-based balloon-catheter induction will be welcomed as part of a patient-centred labour-induction care package for pregnant women.

Trial Registration: Australia New Zealand Clinical Trials Registry (ANZCTR), ACTRN: 12616000739415. Registered on 6 June 2016.

Citing Articles

Outpatient Induction of Labor - Are Balloon Catheters an Appropriate Method?.

Rath W, Stelzl P, Kehl S Geburtshilfe Frauenheilkd. 2021; 81(1):70-80.

PMID: 33487667 PMC: 7815336. DOI: 10.1055/a-1308-2341.


Home versus inpatient induction of labour for improving birth outcomes.

Alfirevic Z, Gyte G, Pileggi V, Plachcinski R, Osoti A, Finucane E Cochrane Database Syst Rev. 2020; 8:CD007372.

PMID: 32852803 PMC: 8094591. DOI: 10.1002/14651858.CD007372.pub4.

References
1.
Turnbull D, Adelson P, Oster C, Bryce R, Fereday J, Wilkinson C . Psychosocial outcomes of a randomized controlled trial of outpatient cervical priming for induction of labor. Birth. 2014; 40(2):75-80. DOI: 10.1111/birt.12035. View

2.
Dencker A, Taft C, Bergqvist L, Lilja H, Berg M . Childbirth experience questionnaire (CEQ): development and evaluation of a multidimensional instrument. BMC Pregnancy Childbirth. 2010; 10:81. PMC: 3008689. DOI: 10.1186/1471-2393-10-81. View

3.
Henry A, Madan A, Reid R, Tracy S, Austin K, Welsh A . Outpatient Foley catheter versus inpatient prostaglandin E2 gel for induction of labour: a randomised trial. BMC Pregnancy Childbirth. 2013; 13:25. PMC: 3564932. DOI: 10.1186/1471-2393-13-25. View

4.
Sciscione A, Muench M, Pollock M, Jenkins T, Colmorgen G . Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol. 2001; 98(5 Pt 1):751-6. DOI: 10.1016/s0029-7844(01)01579-4. View

5.
Thomas J, Fairclough A, Kavanagh J, Kelly A . Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2014; (6):CD003101. PMC: 7138281. DOI: 10.1002/14651858.CD003101.pub3. View